Mouse polyclonal to TNFRSF19L, Host Mouse
- Known as:
- Mouse pab TNFRSF19L, Host Mouse
- Catalog number:
- YF-PA26757
- Product Quantity:
- 50 uL
- Category:
- -
- Supplier:
- Abfron
- Gene target:
- Mouse polyclonal TNFRSF19L Host
Related genes to: Mouse polyclonal to TNFRSF19L, Host Mouse
- Gene:
- RELT NIH gene
- Name:
- RELT TNF receptor
- Previous symbol:
- TNFRSF19L
- Synonyms:
- FLJ14993
- Chromosome:
- 11q13.2
- Locus Type:
- gene with protein product
- Date approved:
- 2002-02-08
- Date modifiied:
- 2019-01-25
Related products to: Mouse polyclonal to TNFRSF19L, Host Mouse
Related articles to: Mouse polyclonal to TNFRSF19L, Host Mouse
- Endometriosis is a multifaceted disease, causing debilitating pelvic pain in some patients, while being completely asymptomatic in others. The pathophysiology of endometriosis pain is not well understood and poorly correlated to stage. We hypothesized that this clinical heterogeneity may be explained by examining differences in gene expression. We performed RNA sequencing of 27 formalin-fixed, paraffin-embedded peritoneal biopsies from 9 symptomatic (Sx) and 10 asymptomatic (ASx) subjects. 890 genes were differentially expressed between Sx and ASx samples. Of these, the most significant including genes involved inflammatory signaling (IL16, IL17RA, JAK3, SMPD3, RELT), cell adhesion (OLFML1, CDON, VCAN), and neuromodulation (SEMA6D, ADRA2C, SLC7A5). Gene Set Enrichment Analysis identified functional enrichment in 22 gene ontology (GO) pathways, of which 7 represented immunologic pathways. Weighted Gene Correlation Network Analysis (WGCNA) identified 11 co-expression modules significantly correlated with symptomaticity, including one module strongly enriched for immunologic/inflammatory functions. Of all molecules identified as associated with pain, IL16 expression also correlated with symptom severity when cases were stratified into mild vs. severe pain based on clinical criteria. These findings suggest that endometriotic lesions of symptomatic subjects are characterized by distinct molecular signatures, including altered expression of inflammatory pathways, highlighting potential mechanisms underlying symptom variability and identifying candidate pathways for future therapeutic interventions. - Source: PubMed
Publication date: 2026/09/10
Mamillapalli RamanaiahLi Howard JApelian ShantKumar MonishWang Sarah FPondugula NishitaCampos Gabriela de QueirozSayeed SumaiyaCho YongheeTaylor Hugh S - - Source: PubMed
Publication date: 2026/07/29
Yao WenjianLiu JianHou ZhaoyaoJia XiangboYang DongFeng MingyuWu SenWei Li - Pediatric liver retransplantation (ReLT) remains technically complex and is associated with increased postoperative complications and mortality. However, pediatric-specific data including surgical challenges are limited. This retrospective single-center study evaluated long-term outcomes, complications, and surgical considerations of pediatric ReLT. - Source: PubMed
Kojima MasatoSakamoto SeisukeUchida HajimeOshiro AyaneCai PengKiataramkul ChanokkamolKomine RyujiYanagi YusukeFukuda AkinariKasahara Mureo - The impact of Karnofsky Performance Status (KPS), a clinical measure of functional status, on liver retransplantation (re-LT) outcomes, is unknown. - Source: PubMed
Publication date: 2026/06/25
Thuluvath Avesh JZhang HelenYerneni SharmithaVerna Elizabeth C - Due to the limited data available among middle-income countries, we aimed to determine the characteristics, outcomes and associated factors with death or graft failure in pediatric liver transplantation (LT). - Source: PubMed
Publication date: 2026/06/20
Getsuwan SongponTovikkai ChutwichaiTubjareon ChomchanatGesprasert GoragochTantemsapya NiramolEiamkulbutr SuthaChongsrisawat VoranushNonthasoot BunthoonThirapattaraphan ChollasakJunrungsee SunhawitLertudomphonwanit ChatmaneePugkhem AkeLumpaopong AdisornTreepongkaruna Suporn